Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Simona Pop"'
Autor:
Christophe Le Tourneau, Simona Pop, Livia Lumbroso-Le Rouic, Olivier Huillard, Christine Levy, Marie-Paule Sablin, Laurence Desjardins, Silvin Bakalian
Publikováno v:
European Journal of Cancer. 50:638-648
When using molecularly targeted agents (MTAs), oncologists and patients face new and sometimes unexpected toxicities. Though ocular adverse events (OAEs) are not uncommon with chemotherapy, they are rarely severe or dose limiting. Ocular toxicity pro
Autor:
Valérie Laurence, M-E Dujaric, Bernard Asselain, Véronique Diéras, Sophie Piperno-Neumann, C. Le Tourneau, Paul-Henri Cottu, P. Beuzeboc, Suzy Scholl, J-Y Pierga, Thierry Dorval, L. Mignot, Simona Pop
Publikováno v:
Annals of Oncology. 25:iv133
Background: A pooled analysis of individual patient data from three randomized phase III trials of first-line bevacizumab-containing therapy for HER2-negative ABC (E2100, AVADO and RIBBON1) demonstrated significantly improved PFS and response rate in
Autor:
Olivier Huillard, M.P. Sablin, Livia Lumbroso, S. Bakalian, C. Le Tourneau, Christine Levy, Laurence Desjardins, Véronique Diéras, Simona Pop
Publikováno v:
Annals of Oncology. 23:ix519
Background MTAs display different toxicity profiles than conventional cytotoxic agents, with primarily non-hematological toxicity. This study aimed to describe the OAEs reported with the use of MTAs approved in oncology. Methods EMEA and FDA product